LL-37 (Cathelicidin) Peptide
LL-37 (Cathelicidin) Peptide
$92.00 Add to cart

LL-37 (Cathelicidin) Peptide

$92.00

For Research Use Only. Not for human use. Research-grade LL-37 (Cathelicidin, CAP-18) is the human 37-amino-acid antimicrobial peptide (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES), intended for controlled in vitro investigations of innate immunity mechanisms, microbial membrane disruption, inflammatory signaling modulation, and epithelial defense pathways in laboratory settings.

In stock

For Research Use Only — Not for Human Consumption
 

Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

For Research Use Only. Not for human use.

LL-37 is the only human cathelicidin antimicrobial peptide, cleaved from the C-terminal of the hCAP-18 precursor protein in neutrophils, macrophages, and epithelial cells. This α-helical, cationic peptide is of significant scientific interest for its broad-spectrum activity against bacteria, viruses, fungi, and biofilms, as well as its role in modulating innate immune responses, including chemotaxis and cytokine regulation. Discovered in the 1990s, it is a cornerstone of laboratory research on innate defense mechanisms and inflammatory pathways. This research-grade lyophilized powder is synthesized under strict quality controls and provided with full analytical documentation. For in vitro and laboratory research purposes only.

Key Scientific Attributes

  • High-purity LL-37 (≥99% by HPLC/MS, acetate salt form)
  • Verified 37-amino-acid sequence: LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
  • Lyophilized formulation for maximum long-term stability
  • Full Certificate of Analysis (COA) with HPLC, MS, and amino acid analysis
  • Manufactured in GMP-aligned, ISO-compliant facilities
  • Suitable for innate immunity, biofilm disruption, and epithelial barrier laboratory studies

Research-Referenced Attributes (Based on published scientific literature; provided for laboratory research context only. Not intended as health, therapeutic, or clinical claims.)

  • Broad antimicrobial spectrum in vitro: studied for disruption of gram-positive and gram-negative bacterial membranes and biofilm models (ncbi.nlm.nih.gov)
  • Investigated the epithelial barrier and re-epithelializationin  cell-based assay models
  • Studied for modulation of inflammatory signaling pathways, including chemotaxis and cytokine expression in laboratory settings (pmc.ncbi.nlm.nih.gov)
  • Used in autoimmune disease in vitro research models
  • Investigated for antiviral activity against enveloped viruses and membrane-targeting mechanisms in laboratory studies (mdpi.com)
  • Relevant to infection, inflammation, and autoimmune in vitro research applications

Why Researchers Choose This LL-37

  • Exact human cathelicidin sequence used in landmark published antimicrobial studies (sciencedirect.com)
  • Transparent analytical data (HPLC ≥99%, MS confirmation)
  • Suitable for immunology, microbiology, and epithelial biology laboratory applications
  • Competitive research pricing with bulk options available

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in
Size

5mg, 10mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.